{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T13:12:54Z","timestamp":1711717974351},"reference-count":61,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1586\/ehm.10.45","type":"journal-article","created":{"date-parts":[[2010,8,13]],"date-time":"2010-08-13T14:00:20Z","timestamp":1281708020000},"page":"485-495","source":"Crossref","is-referenced-by-count":2,"title":["Follicular lymphoma: emerging therapeutic strategies"],"prefix":"10.1586","volume":"3","author":[{"given":"Vaishalee P","family":"Kenkre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brad S","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"CIT0001","first-page":"213","volume":"19","author":"Ganti","year":"2005","journal-title":"Oncology"},{"key":"CIT0002","unstructured":"Swerdlow SH, Campo E, Harris, NLet al.WHO Classification of Tumours of Hamatopoietic and Lymphoid Tissues. International Agency for Research on Cancer, Lyon, France, 220\u2013226 (2008)."},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMcibr067155","volume":"356","author":"Staudt","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"Solal-C\u00e9ligny","year":"2004","journal-title":"Blood"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","volume":"27","author":"Federico","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"CIT0006","first-page":"11","volume":"25","author":"Young","year":"1988","journal-title":"Semin. Hematol."},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1200\/JCO.1997.15.3.1110","volume":"15","author":"Brice","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(03)14110-4","volume":"362","author":"Ardeshna","year":"2003","journal-title":"Lancet"},{"key":"CIT0009","first-page":"75","volume":"20","author":"Horning","year":"1993","journal-title":"Semin. Oncol."},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.1200\/JCO.2004.00.9217","volume":"25","author":"Fisher","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1200\/JCO.2005.04.503","volume":"23","author":"Swenson","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.3696"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","volume":"106","author":"Hiddeman","year":"2005","journal-title":"Blood"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2004-08-3175","volume":"105","author":"Marcus","year":"2005","journal-title":"Blood"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.5376"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.4618"},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1182\/blood-2008-04-153189","volume":"112","author":"Salles","year":"2008","journal-title":"Blood"},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1200\/JCO.2008.18.1495","volume":"27","author":"Friedberg","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1200\/JCO.2005.03.7952","volume":"24","author":"Hagenbeek","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2004.07.170","volume":"22","author":"Zinzani","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"CIT0021","doi-asserted-by":"crossref","unstructured":"Rummel MJ, Niederle N, Maschmeyer Get al.Bendamustine plus rituximab is superior in respect of progression free survival and CR rate when compared to CHOP plus rituximab as first-line treatment of patients with advanced follicular, indolent, and mantle cell lymphomas: final results of a randomized Phase III study of the StiL (Study Group Indolent Lymphomas, Germany), Presented at: 51stAnnual American Society of Hematology Meeting. New Orleans, LA, USA, 5\u20138 December 2009.","DOI":"10.1182\/blood.V114.22.405.405"},{"key":"CIT0022","doi-asserted-by":"crossref","unstructured":"Hochster HS, Weller E, Ryan Tet al.Results of E1496: a Phase III trial of CVP with or without maintenance rituximab in advanced indolent lymphoma (NHL). Presented at:40th Annual American Society of Clinical Oncology Meeting. New Orleans, LA, USA, 5\u20138 June 2004.","DOI":"10.1200\/jco.2004.22.90140.6502"},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1200\/JCO.2006.05.8198","volume":"24","author":"Press","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1200\/JCO.2008.17.2015","volume":"26","author":"Morschhauser","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"CIT0025","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1200\/JCO.2009.22.6258","volume":"27","author":"Goff","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"CIT0026","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJMoa041511","volume":"352","author":"Kaminski","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/1097-0142(197904)43:4<1245::AID-CNCR2820430412>3.0.CO;2-Z","volume":"43","author":"Chen","year":"1979","journal-title":"Cancer"},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/1097-0142(19831215)52:12<2300::AID-CNCR2820521224>3.0.CO;2-Y","volume":"52","author":"Paryani","year":"1983","journal-title":"Cancer"},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/bjc.1994.213","volume":"69","author":"Vaughan Hudson","year":"1994","journal-title":"Br. J. Cancer"},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2005.08.010","volume":"64","author":"Guadagnolo","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"CIT0031","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1200\/JCO.2005.08.100","volume":"3","author":"Rummel","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"CIT0032","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1200\/JCO.2008.17.0001","volume":"26","author":"Robinson","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"CIT0033","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/cncr.24714","volume":"116","author":"Kahl","year":"2010","journal-title":"Cancer"},{"key":"CIT0034","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3816\/CLML.2010.n.002","volume":"10","author":"Cheson","year":"2010","journal-title":"Clin. Lymphoma Myeloma"},{"key":"CIT0035","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1182\/blood-2009-08-233155","volume":"115","author":"De Bella","year":"2010","journal-title":"Blood"},{"key":"CIT0036","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1200\/JCO.2005.02.050","volume":"23","author":"O\u2019Connor","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"CIT0037","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1200\/JCO.2008.17.7980","volume":"27","author":"de Vos","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"CIT0038","doi-asserted-by":"crossref","unstructured":"Fowler N, Kahl BS, Rosen Pet al.Bortezomib, bendamustine, and rituximab in patients with relapsed or refractory follicular lymphoma: encouraging activity in the Phase 2 VERTICAL study. Presented at:51st Annual American Society of Hematology Meeting. New Orleans, LA, USA, 5\u20138 December 2009.","DOI":"10.1182\/blood.V114.22.933.933"},{"key":"CIT0039","unstructured":"Friedberg JW, Vose JM, Kelly JLet al.Bendamustine, bortezomib, and rituximab in patients relapsed\/refractory indolent and mantle cell non-Hodgkin lymphoma (NHL): a multicenter Phase II clinical trial. Presented at:51st Annual American Society of Hematology Meeting, New Orleans, LA, USA, 5\u20138 December 2009."},{"key":"CIT0040","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1200\/JCO.2008.21.1169","volume":"27","author":"Witzig","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"CIT0041","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1182\/blood-2006-05-021113","volume":"108","author":"van Oers","year":"2006","journal-title":"Blood"},{"key":"CIT0042","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1182\/blood-2004-01-0039","volume":"104","author":"Teeling","year":"2004","journal-title":"Blood"},{"key":"CIT0043","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1182\/blood-2007-10-117671","volume":"111","author":"Hagenbeek","year":"2008","journal-title":"Blood"},{"key":"CIT0044","doi-asserted-by":"crossref","unstructured":"Hagenbeek A, Fayad L, Delwail Vet al.Evaluation of ofatumumab, a novel human CD20 monoclonal antibody, as single agent therapy in rituximab-refractory follicular lymphoma. Presented at:51st Annual American Society of Hematology Meeting. New Orleans, LA, USA, 5\u20138 December 2009.","DOI":"10.1182\/blood.V114.22.935.935"},{"key":"CIT0045","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1200\/JCO.2002.11.076","volume":"20","author":"Witzig","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"CIT0046","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1200\/JCO.1999.17.12.3793","volume":"17","author":"Witzig","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.00.9217"},{"key":"CIT0048","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood-2008-05-160200","volume":"113","author":"Gyan","year":"2009","journal-title":"Blood"},{"key":"CIT0049","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2004-03-0982","volume":"104","author":"Lenz","year":"2004","journal-title":"Blood"},{"key":"CIT0050","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1182\/blood-2007-10-116749","volume":"111","author":"Ladetto","year":"2008","journal-title":"Blood"},{"key":"CIT0051","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.2003.10.023","volume":"21","author":"Schouten","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"CIT0052","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1200\/JCO.2006.09.8327","volume":"25","author":"Rohatiner","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"CIT0053","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.bmt.1702191","volume":"25","author":"Toze","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"CIT0054","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bmt.1701556","volume":"23","author":"Stein","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"CIT0055","first-page":"1832","volume":"92","author":"van Besien","year":"1998","journal-title":"Blood"},{"key":"CIT0056","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bmt.1703891","volume":"31","author":"Peniket","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"CIT0057","doi-asserted-by":"crossref","unstructured":"van Besien K. Allogeneic stem cell transplantation in follicular lymphoma: recent progress and controversy. Presented at:51st Annual American Society of Hematology Meeting.New Orleans, LA, USA 5\u20138 December 2009.","DOI":"10.1182\/asheducation-2009.1.610"},{"key":"CIT0058","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbmt.2007.11.004","volume":"14","author":"Hari","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"key":"CIT0059","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1182\/blood-2007-07-098483","volume":"111","author":"Sorror","year":"2008","journal-title":"Blood"},{"key":"CIT0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1200\/JCO.2007.11.5477","volume":"26","author":"Rezvani","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"CIT0061","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1182\/blood-2008-01-136242","volume":"111","author":"Khouri","year":"2008","journal-title":"Blood"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/ehm.10.45","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T12:38:39Z","timestamp":1711715919000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/ehm.10.45"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":61,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,1,10]]},"published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1586\/ehm.10.45"],"URL":"https:\/\/doi.org\/10.1586\/ehm.10.45","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}